The abstract is read at the publisher; the summary is JClub's.
Machine learning is enabling scalable discovery and design of peptides, yielding new antibiotic agents against priority pathogens and uncovering unexpected roles in host immunity.
- Why it matters: Systematically designing peptide activity remains difficult, limiting biology and medicine; AI offers a way to mine sequence data and connect design to function.
- What they did: The review surveys AI workflows for activity prediction, structure–activity modeling, sequence optimization, and de novo generation, paired with in silico design and high-throughput experimental validation.
- The result: It also frames “encrypted immunity,” where ordinary proteins encode latent antimicrobial fragments, outlining translational opportunities and key remaining challenges for clinical use.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.